^
Association details:
Evidence:
Evidence Level:
Resistant: D – Preclinical
New
Title:

Elevation of c-FLIP in castrate-resistant prostate cancer antagonizes therapeutic response to androgen receptor-targeted therapy

Excerpt:
Conversely, the elevated expression of c-FLIP detected in the CRPC cell line VCaP underpinned their insensitivity to bicalutamide and SAHA in vitro.
DOI:
10.1158/1078-0432.CCR-11-3277